Literature DB >> 28202388

Viral Vector Reprogramming of Adult Resident Striatal Oligodendrocytes into Functional Neurons.

Marc S Weinberg1, Hugh E Criswell2, Sara K Powell1, Aadra P Bhatt3, Thomas J McCown4.   

Abstract

Recent advances suggest that in vivo reprogramming of endogenous cell populations provides a viable alternative for neuron replacement. Astrocytes and oligodendrocyte precursor cells can be induced to transdifferentiate into neurons in the CNS, but, in these instances, reprogramming requires either transgenic mice or retroviral-mediated gene expression. We developed a microRNA (miRNA)-GFP construct that in vitro significantly reduced the expression of polypyrimidine tract-binding protein, and, subsequently, we packaged this construct in a novel oligodendrocyte preferring adeno-associated virus vector. Ten days after rat striatal transduction, the vast majority of the GFP-positive cells were oligodendrocytes, but 6 weeks to 6 months later, the majority of GFP-positive cells exhibited neuronal morphology and co-localized with the neuronal marker NeuN. Patch-clamp studies on striatal slices established that the GFP-positive cells exhibited electrophysiological properties indicative of mature neurons, such as spontaneous action potentials and spontaneous inhibitory postsynaptic currents. Also, 3 months after striatal vector administration, GFP-positive terminals in the ipsilateral globus pallidus or substantia nigra retrogradely transported fluorescent beads back to GFP-positive striatal cell bodies, indicating the presence of functional presynaptic terminals. Thus, this viral vector approach provides a potential means to harness resident oligodendrocytes as an endogenous source for in vivo neuronal replacement.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adeno-associated virus; gene therapy; neurons; oligodendrocytes; reprogramming; transdifferentiation

Mesh:

Substances:

Year:  2017        PMID: 28202388      PMCID: PMC5383550          DOI: 10.1016/j.ymthe.2017.01.016

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  21 in total

1.  Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.

Authors:  Cassia N Cearley; John H Wolfe
Journal:  Mol Ther       Date:  2006-01-18       Impact factor: 11.454

2.  Reciprocal actions of REST and a microRNA promote neuronal identity.

Authors:  Cecilia Conaco; Stefanie Otto; Jong-Jin Han; Gail Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

Review 3.  In vivo reprogramming for tissue repair.

Authors:  Christophe Heinrich; Francesca M Spagnoli; Benedikt Berninger
Journal:  Nat Cell Biol       Date:  2015-03       Impact factor: 28.824

4.  Increased population of oligodendroglia-like cells in pediatric intractable epilepsy.

Authors:  Satoru Sakuma; William C Halliday; Ruka Nomura; Ayako Ochi; Hiroshi Otsubo
Journal:  Neurosci Lett       Date:  2014-03-12       Impact factor: 3.046

5.  Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.

Authors:  Yuanyuan Luo; Qiao Hu; Qian Zhang; Siqi Hong; Xiaoju Tang; Li Cheng; Li Jiang
Journal:  Brain Res       Date:  2015-10-04       Impact factor: 3.252

6.  Generation of induced neurons via direct conversion in vivo.

Authors:  Olof Torper; Ulrich Pfisterer; Daniel A Wolf; Maria Pereira; Shong Lau; Johan Jakobsson; Anders Björklund; Shane Grealish; Malin Parmar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

7.  Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.

Authors:  Yuanchao Xue; Kunfu Ouyang; Jie Huang; Yu Zhou; Hong Ouyang; Hairi Li; Gang Wang; Qijia Wu; Chaoliang Wei; Yanzhen Bi; Li Jiang; Zhiqiang Cai; Hui Sun; Kang Zhang; Yi Zhang; Ju Chen; Xiang-Dong Fu
Journal:  Cell       Date:  2013-01-11       Impact factor: 41.582

8.  In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model.

Authors:  Ziyuan Guo; Lei Zhang; Zheng Wu; Yuchen Chen; Fan Wang; Gong Chen
Journal:  Cell Stem Cell       Date:  2013-12-19       Impact factor: 24.633

9.  Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex.

Authors:  Christophe Heinrich; Matteo Bergami; Sergio Gascón; Alexandra Lepier; Francesca Viganò; Leda Dimou; Bernd Sutor; Benedikt Berninger; Magdalena Götz
Journal:  Stem Cell Reports       Date:  2014-11-20       Impact factor: 7.765

10.  After Intracerebral Hemorrhage, Oligodendrocyte Precursors Proliferate and Differentiate Inside White-Matter Tracts in the Rat Striatum.

Authors:  Michael J E Joseph; Jayalakshmi Caliaperumal; Lyanne C Schlichter
Journal:  Transl Stroke Res       Date:  2016-01-08       Impact factor: 6.829

View more
  15 in total

Review 1.  MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases.

Authors:  Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-06-29       Impact factor: 5.590

Review 2.  Reprogramming Glial Cells into Functional Neurons for Neuro-regeneration: Challenges and Promise.

Authors:  Fengchao Wang; Leping Cheng; Xiaohui Zhang
Journal:  Neurosci Bull       Date:  2021-07-20       Impact factor: 5.203

3.  Adeno-Associated Virus Capsid-Promoter Interactions in the Brain Translate from Rat to the Nonhuman Primate.

Authors:  Martin O Bohlen; Thomas J McCown; Sara K Powell; Hala G El-Nahal; Tierney Daw; Michele A Basso; Marc A Sommer; R Jude Samulski
Journal:  Hum Gene Ther       Date:  2020-10-22       Impact factor: 5.695

Review 4.  From Progenitors to Progeny: Shaping Striatal Circuit Development and Function.

Authors:  Rhys Knowles; Nathalie Dehorter; Tommas Ellender
Journal:  J Neurosci       Date:  2021-11-17       Impact factor: 6.167

5.  Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?

Authors:  Huadong Xu; Xu Cheng; Qian Song; Yuxin Yang; Changhe Wang; Xinjiang Kang
Journal:  Neurosci Bull       Date:  2022-02-23       Impact factor: 5.271

6.  AAV Capsid-Promoter Interactions Determine CNS Cell-Selective Gene Expression In Vivo.

Authors:  Sara K Powell; R Jude Samulski; Thomas J McCown
Journal:  Mol Ther       Date:  2020-03-17       Impact factor: 11.454

7.  Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB.

Authors:  Roy Maimon; Carlos Chillon-Marinas; Cedric E Snethlage; Sarthak M Singhal; Melissa McAlonis-Downes; Karen Ling; Frank Rigo; C Frank Bennett; Sandrine Da Cruz; Thomas S Hnasko; Alysson R Muotri; Don W Cleveland
Journal:  Nat Neurosci       Date:  2021-06-03       Impact factor: 24.884

8.  Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Weizhao Chen; Qiongping Zheng; Qiaoying Huang; Shanshan Ma; Mingtao Li
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

9.  The Chromatin Environment Around Interneuron Genes in Oligodendrocyte Precursor Cells and Their Potential for Interneuron Reprograming.

Authors:  Linda L Boshans; Daniel C Factor; Vijender Singh; Jia Liu; Chuntao Zhao; Ion Mandoiu; Q Richard Lu; Patrizia Casaccia; Paul J Tesar; Akiko Nishiyama
Journal:  Front Neurosci       Date:  2019-08-08       Impact factor: 4.677

Review 10.  Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?

Authors:  Sudhanshu P Raikwar; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Pushpavathi Govindhasamy Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.